Landos Biopharma, Inc. Operating Income 2021-2024 | LABP
Landos Biopharma, Inc. operating income from 2021 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Landos Biopharma, Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-23 |
| 2022 | $-41 |
| 2021 | $-39 |
| 2020 | $-31 |
| 2019 | $-13 |
| Landos Biopharma, Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-9 |
| 2023-12-31 | $-7 |
| 2023-09-30 | $-5 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $-7 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $-15 |
| 2021-12-31 | $-20 |
| 2021-09-30 | $-12 |
| 2021-06-30 | $4 |
| 2021-03-31 | $-10 |
| 2020-12-31 | $-11 |
| 2020-09-30 | $-8 |
| 2020-06-30 | $-5 |
| 2020-03-31 | $-6 |
